Dr. Johnny Kao, MD
Claim this profileGood Samaritan Hospital Medical Center
Affiliated Hospitals
Good Samaritan Hospital Medical Center
Good Samaritan University Hospital
Clinical Trials Johnny Kao, MD is currently running
SBRT vs Standard Radiation
for Cancer
This phase II trial studies how well single-fraction stereotactic body radiation therapy (SBRT) works when compared to standard radiation therapy in treating patients with cancer that has spread to other places in the body (metastatic). Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue.
Recruiting
1 award
Phase 2
7 criteria
Nurse-Led Palliative Care
for Advanced Cancer
The purpose of the randomized control trial is to estimate the effect of an oncology clinical nurse specialist-led early intervention multidisciplinary approach to palliative and survivorship care within two previously identified and validated patient groups having metastatic solid tumor malignancy on patient-reported symptom burden, patient-reported overall quality of life (QOL), distress, and overall survival. The primary hypothesis is that the effect of an oncology clinical nurse specialist- led early intervention multidisciplinary palliative and survivorship care model will be significantly higher, as compared to the standard of care approach to palliative and survivorship care, on the primary endpoint of patient-reported symptom burden for patients with metastatic solid tumor malignancy within favorable and very favorable risk groups. Symptom burden includes pain, tiredness, drowsiness, nausea, lack of appetite, depression, anxiety, shortness of breath, and wellbeing.
Recruiting
1 award
N/A
1 criteria
More about Johnny Kao, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Johnny Kao, MD has experience with
- Conventional Whole Brain RT
- Whole Brain IMRT
- Palliative And Survivorship Care Model
- Palliative Radiation Therapy
- Single-Fraction SBRT
Breakdown of trials Johnny Kao, MD has run
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Johnny Kao, MD specialize in?
Johnny Kao, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Johnny Kao, MD currently recruiting for clinical trials?
Yes, Johnny Kao, MD is currently recruiting for 2 clinical trials in West Islip New York. If you're interested in participating, you should apply.
Are there any treatments that Johnny Kao, MD has studied deeply?
Yes, Johnny Kao, MD has studied treatments such as Conventional Whole Brain RT, Whole Brain IMRT, Palliative and Survivorship Care Model.
What is the best way to schedule an appointment with Johnny Kao, MD?
Apply for one of the trials that Johnny Kao, MD is conducting.
What is the office address of Johnny Kao, MD?
The office of Johnny Kao, MD is located at: Good Samaritan Hospital Medical Center, West Islip, New York 11795 United States. This is the address for their practice at the Good Samaritan Hospital Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.